The new version 5 software has been released for the XO in-process particle size analysis range from Xoptix Ltd. This version launches a host of new features, which will be made available to all Xoptix customers. One very significant feature includes 21 CFR part 11 compliant, supporting their expansion into the pharmaceutical marketplace.

Xoptix Limited have released a new software version for their XO particle sizer range, designed for process applications. One of the most significant additions is that the new version 5 software release is 21 CFR part 11 compliant, which could well be a clue as to the eagerly awaited new product launch at POWTECH 2014, held in Germany later this month.

The XO in-process particle sizer measures from 0.1 to 3000 micron in real-time. It’s backed by an R&D Team based at their Headquarters in Worcestershire, England, who continually evolve and develop the product range. The version 5 software release welcomes new flexible user functionality and additional alarm reporting, plus historical data is made even easier to process.

Richard Graves, Technical Director at Xoptix Limited explains “We’re looking forward to demonstrating the new version 5 software for our particle sizers at POWTECH at the end of the month. We’ve listened to our customers and all the new features are designed to enhance the user experience. Version 5 is a particular landmark for the company as it is 21 CFR part 11 compliant, allowing us to move into new markets that require more stringent regulations”.

The XO range of particle sizers can be used for wet or dry applications and monitor in real-time, eliminating the need for laboratory analysis. It’s easy to use with a robust and stable unit, offering efficiency and cost savings to processes from day one.

For more information regarding the new software release from Xoptix visit, email

This story is reprinted from material from Xoptix, with editorial changes made by Materials Today. The views expressed in this article do not necessarily represent those of Elsevier.